rs778439872

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000219.6(KCNE1):​c.118G>A​(p.Gly40Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G40V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 12)
Exomes 𝑓: 0.000027 ( 10 hom. )
Failed GnomAD Quality Control

Consequence

KCNE1
NM_000219.6 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.677

Publications

2 publications found
Variant links:
Genes affected
KCNE1 (HGNC:6240): (potassium voltage-gated channel subfamily E regulatory subunit 1) The product of this gene belongs to the potassium channel KCNE family. Potassium ion channels are essential to many cellular functions and show a high degree of diversity, varying in their electrophysiologic and pharmacologic properties. This gene encodes a transmembrane protein known to associate with the product of the KVLQT1 gene to form the delayed rectifier potassium channel. Mutation in this gene are associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
KCNE1 Gene-Disease associations (from GenCC):
  • long QT syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Jervell and Lange-Nielsen syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014184296).
BP6
Variant 21-34449517-C-T is Benign according to our data. Variant chr21-34449517-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 527042.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE1NM_000219.6 linkc.118G>A p.Gly40Ser missense_variant Exon 4 of 4 ENST00000399286.3 NP_000210.2 P15382C7S316Q6FHJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE1ENST00000399286.3 linkc.118G>A p.Gly40Ser missense_variant Exon 4 of 4 1 NM_000219.6 ENSP00000382226.2 P15382

Frequencies

GnomAD3 genomes
Cov.:
12
GnomAD2 exomes
AF:
0.000183
AC:
46
AN:
251398
AF XY:
0.000140
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000270
AC:
23
AN:
853144
Hom.:
10
Cov.:
23
AF XY:
0.0000259
AC XY:
11
AN XY:
424408
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
16646
American (AMR)
AF:
0.00
AC:
0
AN:
28880
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
14030
East Asian (EAS)
AF:
0.000155
AC:
3
AN:
19360
South Asian (SAS)
AF:
0.000122
AC:
6
AN:
49060
European-Finnish (FIN)
AF:
0.0000277
AC:
1
AN:
36162
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3458
European-Non Finnish (NFE)
AF:
0.0000200
AC:
13
AN:
650764
Other (OTH)
AF:
0.00
AC:
0
AN:
34784
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0662318), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
12
Alfa
AF:
0.0000555
Hom.:
0
ExAC
AF:
0.000231
AC:
28
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Dec 01, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KCNE1-related disorder Benign:1
Feb 16, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Long QT syndrome Benign:1
Dec 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 28, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
0.77
DANN
Benign
0.79
DEOGEN2
Benign
0.40
T;T;T;T;T;T;T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.44
.;.;T;.;.;.;.;.
M_CAP
Benign
0.052
D
MetaRNN
Benign
0.014
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.64
T
MutationAssessor
Benign
-0.010
N;N;N;N;N;N;N;N
PhyloP100
-0.68
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.17
N;.;.;N;N;N;N;N
REVEL
Benign
0.26
Sift
Benign
0.47
T;.;.;T;T;T;T;T
Sift4G
Benign
0.55
T;T;T;T;T;T;T;T
Polyphen
0.0010
B;B;B;B;B;B;B;B
Vest4
0.023
MutPred
0.19
Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);Gain of phosphorylation at G40 (P = 0.0595);
MVP
0.48
MPC
0.077
ClinPred
0.020
T
GERP RS
-6.5
Varity_R
0.035
gMVP
0.42
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs778439872; hg19: chr21-35821815; API